Abstract |
Ginkgolide C (GGC) derived from Ginkgo biloba, has been reported to exhibit various biological functions. However, the anti-neoplastic effect of GGC and its mechanisms in liver cancer have not been studied previously. Hepatocyte growth factor (HGF)/c-mesenchymal-epithelial transition receptor (c-Met) pathway can regulate tumor growth and metastasis in hepatocellular carcinoma (HCC) cells. This study aimed to evaluate the anti-neoplastic effect of GGC against HCC cells and we observed that GGC inhibited HGF-induced c-Met and c-Met downstream oncogenic pathways, such as PI3K/Akt/mTOR and MEK/ERK. In addition, GGC also suppressed the proliferation of expression of diverse tumorigenic proteins (Bcl-2, Bcl-xL, Survivin, IAP-1, IAP-2, Cyclin D1, and COX-2) and induced apoptosis. Interestingly, the silencing of c-Met by small interfering RNA ( siRNA) mitigated c-Met expression and enhanced GGC-induced apoptosis. Moreover, it was noted that GGC also significantly reduced the invasion and migration of HCC cells. Overall, the data clearly demonstrate that GGC exerts its anti-neoplastic activity through modulating c-Met phosphorylation and may be used as an effective therapy against HCC.
|
Authors | Min Hee Yang, Seung Ho Baek, Jae-Young Um, Kwang Seok Ahn |
Journal | International journal of molecular sciences
(Int J Mol Sci)
Vol. 21
Issue 21
(Nov 05 2020)
ISSN: 1422-0067 [Electronic] Switzerland |
PMID | 33167504
(Publication Type: Journal Article)
|
Chemical References |
- Ginkgolides
- Lactones
- ginkgolide C
- Hepatocyte Growth Factor
- Proto-Oncogene Proteins c-met
|
Topics |
- Apoptosis
(drug effects)
- Carcinoma, Hepatocellular
(drug therapy, metabolism)
- Cell Line, Tumor
- Cell Movement
(drug effects)
- Cell Proliferation
(drug effects)
- Epithelial-Mesenchymal Transition
(drug effects)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Ginkgolides
(metabolism, pharmacology)
- Hep G2 Cells
- Hepatocyte Growth Factor
(metabolism)
- Humans
- Lactones
(metabolism, pharmacology)
- Liver Neoplasms
(drug therapy, metabolism)
- Phosphatidylinositol 3-Kinases
(metabolism)
- Phosphorylation
- Proto-Oncogene Proteins c-met
(metabolism)
- Signal Transduction
(drug effects)
|